Jeffrey La Rosa
Stock Analyst at Leerink Partners
(0.13)
# 4,808
Out of 5,162 analysts
25
Total ratings
23.8%
Success rate
-30.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeffrey La Rosa
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences Holdings | Reiterated: Buy | n/a | $0.087 | - | 2 | Dec 15, 2025 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $7 | $1.41 | n/a | 12 | Aug 15, 2025 | |
| JANX Janux Therapeutics | Reiterated: Buy | $87 | $10.31 | n/a | 10 | Aug 12, 2025 | |
| MRK Merck & Co. | Rated: Buy | $112 | $137.78 | n/a | 1 | Oct 28, 2022 |
Senti Biosciences Holdings
Dec 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.087
Upside: -
Pyxis Oncology
Aug 15, 2025
Reiterated: Buy
Price Target: $7
Current: $1.41
Upside: n/a
Janux Therapeutics
Aug 12, 2025
Reiterated: Buy
Price Target: $87
Current: $10.31
Upside: n/a
Merck & Co.
Oct 28, 2022
Rated: Buy
Price Target: $112
Current: $137.78
Upside: n/a